Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2348 entries
Sorted by: Best Match Show Resources per page
[Academic assemblies for nursing profession. JNA Academic Assembly on Nursing].

[Kango] Japanese journal of nursing

Iida S.
PMID: 3650508
Kango. 1987 Feb;39(2):6-15.

No abstract available.

Cite
Iida S. [Academic assemblies for nursing profession. JNA Academic Assembly on Nursing]. Kango. 1987;39(2):6-15
Iida, S. (1987). [Academic assemblies for nursing profession. JNA Academic Assembly on Nursing]. [Kango] Japanese journal of nursing, 39(2), 6-15.
Iida, S. "[Academic assemblies for nursing profession. JNA Academic Assembly on Nursing]." [Kango] Japanese journal of nursing vol. 39,2 (1987): 6-15.
Iida S. [Academic assemblies for nursing profession. JNA Academic Assembly on Nursing]. Kango. 1987 Feb;39(2):6-15. Japanese. PMID: 3650508.
Copy Download .nbib Format: NLM
[Check point in nursing education: effective use of nursing graduates' advice in counseling of nursing students].

Kango tenbo. The Japanese journal of nursing science

Aida F.
PMID: 2615501
Kango Tenbo. 1989 Jul;14(8):860.

No abstract available.

Cite
Aida F. [Check point in nursing education: effective use of nursing graduates' advice in counseling of nursing students]. Kango Tenbo. 1989;14(8):860
Aida, F. (1989). [Check point in nursing education: effective use of nursing graduates' advice in counseling of nursing students]. Kango tenbo. The Japanese journal of nursing science, 14(8), 860.
Aida, F. "[Check point in nursing education: effective use of nursing graduates' advice in counseling of nursing students]." Kango tenbo. The Japanese journal of nursing science vol. 14,8 (1989): 860.
Aida F. [Check point in nursing education: effective use of nursing graduates' advice in counseling of nursing students]. Kango Tenbo. 1989 Jul;14(8):860. Japanese. PMID: 2615501.
Copy Download .nbib Format: NLM
[Check point in nursing education: re-evaluation and improvement of the nursing curriculum with the cooperation of the teaching personnel].

Kango tenbo. The Japanese journal of nursing science

Aida F.
PMID: 2622211
Kango Tenbo. 1989 Aug;14(9):972.

No abstract available.

Cite
Aida F. [Check point in nursing education: re-evaluation and improvement of the nursing curriculum with the cooperation of the teaching personnel]. Kango Tenbo. 1989;14(9):972
Aida, F. (1989). [Check point in nursing education: re-evaluation and improvement of the nursing curriculum with the cooperation of the teaching personnel]. Kango tenbo. The Japanese journal of nursing science, 14(9), 972.
Aida, F. "[Check point in nursing education: re-evaluation and improvement of the nursing curriculum with the cooperation of the teaching personnel]." Kango tenbo. The Japanese journal of nursing science vol. 14,9 (1989): 972.
Aida F. [Check point in nursing education: re-evaluation and improvement of the nursing curriculum with the cooperation of the teaching personnel]. Kango Tenbo. 1989 Aug;14(9):972. Japanese. PMID: 2622211.
Copy Download .nbib Format: NLM
[Surgical success in pulmonary cyst in an infant].

Kyobu geka. The Japanese journal of thoracic surgery

Iida Y, Iida F, Wakao T, Takekawa O, Tei E.
PMID: 5466364
Kyobu Geka. 1970 Jul;23(7):521-4.

No abstract available.

Cite
Iida Y, Iida F, Wakao T, et al. [Surgical success in pulmonary cyst in an infant]. Kyobu Geka. 1970;23(7):521-4
Iida, Y., Iida, F., Wakao, T., Takekawa, O., & Tei, E. (1970). [Surgical success in pulmonary cyst in an infant]. Kyobu geka. The Japanese journal of thoracic surgery, 23(7), 521-4.
Iida, Y, et al. "[Surgical success in pulmonary cyst in an infant]." Kyobu geka. The Japanese journal of thoracic surgery vol. 23,7 (1970): 521-4.
Iida Y, Iida F, Wakao T, Takekawa O, Tei E. [Surgical success in pulmonary cyst in an infant]. Kyobu Geka. 1970 Jul;23(7):521-4. Japanese. PMID: 5466364.
Copy Download .nbib Format: NLM
[Care and education of children with Down's syndrome].

[Kango gijutsu] : [Nursing technique]

Iida M.
PMID: 4274889
Kango Gijutsu. 1974 Feb;20(2):20-9.

No abstract available.

Cite
Iida M. [Care and education of children with Down's syndrome]. Kango Gijutsu. 1974;20(2):20-9
Iida, M. (1974). [Care and education of children with Down's syndrome]. [Kango gijutsu] : [Nursing technique], 20(2), 20-9.
Iida, M. "[Care and education of children with Down's syndrome]." [Kango gijutsu] : [Nursing technique] vol. 20,2 (1974): 20-9.
Iida M. [Care and education of children with Down's syndrome]. Kango Gijutsu. 1974 Feb;20(2):20-9. Japanese. PMID: 4274889.
Copy Download .nbib Format: NLM
Population pharmacokinetics of olprinone in healthy male volunteers.

Clinical pharmacology : advances and applications

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H.
PMID: 24623995
Clin Pharmacol. 2014 Mar 04;6:43-50. doi: 10.2147/CPAA.S50626. eCollection 2014.

BACKGROUND: Olprinone decreases the cardiac preload and/or afterload because of its vasodilatory effect and increases myocardial contractility by inhibiting phosphodiesterase III.PURPOSE: The objective of this study was to characterize the population pharmacokinetics of olprinone after a single continuous infusion...

Cite
Kunisawa T, Kasai H, Suda M, et al. Population pharmacokinetics of olprinone in healthy male volunteers. Clin Pharmacol. 2014;6:43-50doi: 10.2147/CPAA.S50626.
Kunisawa, T., Kasai, H., Suda, M., Yoshimura, M., Sugawara, A., Izumi, Y., Iida, T., Kurosawa, A., & Iwasaki, H. (2014). Population pharmacokinetics of olprinone in healthy male volunteers. Clinical pharmacology : advances and applications, 643-50. https://doi.org/10.2147/CPAA.S50626
Kunisawa, Takayuki, et al. "Population pharmacokinetics of olprinone in healthy male volunteers." Clinical pharmacology : advances and applications vol. 6 (2014): 43-50. doi: https://doi.org/10.2147/CPAA.S50626
Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H. Population pharmacokinetics of olprinone in healthy male volunteers. Clin Pharmacol. 2014 Mar 04;6:43-50. doi: 10.2147/CPAA.S50626. eCollection 2014. PMID: 24623995; PMCID: PMC3949558.
Copy Download .nbib Format: NLM
Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case.

Journal of anesthesia

Takenaka M, Iida H, Ohta S, Dohi S.
PMID: 28921070
J Anesth. 1997 Dec;11(4):300-302. doi: 10.1007/BF02480748.

No abstract available.

Cite
Takenaka M, Iida H, Ohta S, et al. Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. J Anesth. 1997;11(4):300-302doi: 10.1007/BF02480748.
Takenaka, M., Iida, H., Ohta, S., & Dohi, S. (1997). Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. Journal of anesthesia, 11(4), 300-302. https://doi.org/10.1007/BF02480748
Takenaka, Motoyasu, et al. "Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case." Journal of anesthesia vol. 11,4 (1997): 300-302. doi: https://doi.org/10.1007/BF02480748
Takenaka M, Iida H, Ohta S, Dohi S. Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. J Anesth. 1997 Dec;11(4):300-302. doi: 10.1007/BF02480748. PMID: 28921070.
Copy Download .nbib Format: NLM
Dynamic propeller conformation for the unprecedentedly high degree of chiral amplification of supramolecular helices.

Chemical science

Kim T, Mori T, Aida T, Miyajima D.
PMID: 28451111
Chem Sci. 2016 Nov 01;7(11):6689-6694. doi: 10.1039/c6sc02814d. Epub 2016 Jul 12.

An unprecedentedly high degree of chiral amplification of supramolecular helices in a sergeants and soldiers system was realized using a propeller-shaped molecule, triphenylamine (TPA), as the monomer. One sergeant controlled the handedness of 500 soldiers in supramolecular helices. We...

Cite
Kim T, Mori T, Aida T, et al. Dynamic propeller conformation for the unprecedentedly high degree of chiral amplification of supramolecular helices. Chem Sci. 2016;7(11):6689-6694doi: 10.1039/c6sc02814d.
Kim, T., Mori, T., Aida, T., & Miyajima, D. (2016). Dynamic propeller conformation for the unprecedentedly high degree of chiral amplification of supramolecular helices. Chemical science, 7(11), 6689-6694. https://doi.org/10.1039/c6sc02814d
Kim, Taehoon, et al. "Dynamic propeller conformation for the unprecedentedly high degree of chiral amplification of supramolecular helices." Chemical science vol. 7,11 (2016): 6689-6694. doi: https://doi.org/10.1039/c6sc02814d
Kim T, Mori T, Aida T, Miyajima D. Dynamic propeller conformation for the unprecedentedly high degree of chiral amplification of supramolecular helices. Chem Sci. 2016 Nov 01;7(11):6689-6694. doi: 10.1039/c6sc02814d. Epub 2016 Jul 12. PMID: 28451111; PMCID: PMC5355865.
Copy Download .nbib Format: NLM
Serum free IgE guided dose reduction of omalizumab: a case report.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Gon Y, Ito R, Maruoka S, Mizumura K, Kozu Y, Hiranuma H, Iida Y, Shikano S, Hashimoto S.
PMID: 28861109
Allergy Asthma Clin Immunol. 2017 Aug 31;13:39. doi: 10.1186/s13223-017-0211-z. eCollection 2017.

BACKGROUND: Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that...

Cite
Gon Y, Ito R, Maruoka S, et al. Serum free IgE guided dose reduction of omalizumab: a case report. Allergy Asthma Clin Immunol. 2017;13:39doi: 10.1186/s13223-017-0211-z.
Gon, Y., Ito, R., Maruoka, S., Mizumura, K., Kozu, Y., Hiranuma, H., Iida, Y., Shikano, S., & Hashimoto, S. (2017). Serum free IgE guided dose reduction of omalizumab: a case report. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 1339. https://doi.org/10.1186/s13223-017-0211-z
Gon, Yasuhiro, et al. "Serum free IgE guided dose reduction of omalizumab: a case report." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 13 (2017): 39. doi: https://doi.org/10.1186/s13223-017-0211-z
Gon Y, Ito R, Maruoka S, Mizumura K, Kozu Y, Hiranuma H, Iida Y, Shikano S, Hashimoto S. Serum free IgE guided dose reduction of omalizumab: a case report. Allergy Asthma Clin Immunol. 2017 Aug 31;13:39. doi: 10.1186/s13223-017-0211-z. eCollection 2017. PMID: 28861109; PMCID: PMC5577842.
Copy Download .nbib Format: NLM
Differences between pre-existing type and de novo type left convex thoracolumbar / lumbar scoliosis.

Scoliosis

Iida T, Ohyama Y, Katayanagi J, Ato A, Mine K, Matsumoto K, Furukawa H, Tomura T, Ozeki S.
PMID: 25815049
Scoliosis. 2015 Feb 11;10:S6. doi: 10.1186/1748-7161-10-S2-S6. eCollection 2015.

BACKGROUND: Lenke 5C type adolescent idiopathic scoliosis (AIS) with a Cobb angle of over 30 degrees has high risk of progression. The need for corrective surgeries for degenerative lumbar scoliosis has been increasing these days and some of those...

Cite
Iida T, Ohyama Y, Katayanagi J, et al. Differences between pre-existing type and de novo type left convex thoracolumbar / lumbar scoliosis. Scoliosis. 2015;10:S6doi: 10.1186/1748-7161-10-S2-S6.
Iida, T., Ohyama, Y., Katayanagi, J., Ato, A., Mine, K., Matsumoto, K., Furukawa, H., Tomura, T., & Ozeki, S. (2015). Differences between pre-existing type and de novo type left convex thoracolumbar / lumbar scoliosis. Scoliosis, 10S6. https://doi.org/10.1186/1748-7161-10-S2-S6
Iida, Takahiro, et al. "Differences between pre-existing type and de novo type left convex thoracolumbar / lumbar scoliosis." Scoliosis vol. 10 (2015): S6. doi: https://doi.org/10.1186/1748-7161-10-S2-S6
Iida T, Ohyama Y, Katayanagi J, Ato A, Mine K, Matsumoto K, Furukawa H, Tomura T, Ozeki S. Differences between pre-existing type and de novo type left convex thoracolumbar / lumbar scoliosis. Scoliosis. 2015 Feb 11;10:S6. doi: 10.1186/1748-7161-10-S2-S6. eCollection 2015. PMID: 25815049; PMCID: PMC4331766.
Copy Download .nbib Format: NLM
A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review.

Case reports in oncology

Iida K, Kawai N, Naiki T, Etani T, Ando R, Nagai T, Sugiyama Y, Naiki-Ito A, Nishio H, Okada A, Kohri K, Yasui T.
PMID: 26668577
Case Rep Oncol. 2015 Nov 01;8(3):530-5. doi: 10.1159/000442347. eCollection 2015.

Pemetrexed is an antifolate agent that is regarded as an alternative second-line chemotherapy against advanced or metastatic urothelial carcinoma (UC). However, there is limited information on pemetrexed in a third-line setting. We report a case of metastatic UC treated...

Cite
Iida K, Kawai N, Naiki T, et al. A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case Rep Oncol. 2015;8(3):530-5doi: 10.1159/000442347.
Iida, K., Kawai, N., Naiki, T., Etani, T., Ando, R., Nagai, T., Sugiyama, Y., Naiki-Ito, A., Nishio, H., Okada, A., Kohri, K., & Yasui, T. (2015). A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case reports in oncology, 8(3), 530-5. https://doi.org/10.1159/000442347
Iida, Keitaro, et al. "A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review." Case reports in oncology vol. 8,3 (2015): 530-5. doi: https://doi.org/10.1159/000442347
Iida K, Kawai N, Naiki T, Etani T, Ando R, Nagai T, Sugiyama Y, Naiki-Ito A, Nishio H, Okada A, Kohri K, Yasui T. A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case Rep Oncol. 2015 Nov 01;8(3):530-5. doi: 10.1159/000442347. eCollection 2015. PMID: 26668577; PMCID: PMC4677708.
Copy Download .nbib Format: NLM
Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2.

Hepatology international

Seki N, Sugita T, Aida Y, Itagaki M, Ishiguro H, Sutoh S, Abe H, Tsubota A, Matsushima M, Aizawa Y.
PMID: 26202760
Hepatol Int. 2014 Oct;8(4):550-9. doi: 10.1007/s12072-014-9572-2. Epub 2014 Sep 26.

BACKGROUND: The life cycle of hepatitis C virus (HCV) is tightly associated with host lipoprotein metabolic pathways. Apolipoprotein is present on the outer surface of lipoprotein particles and plays an important role in lipoprotein metabolism. We aimed to elucidate...

Cite
Seki N, Sugita T, Aida Y, et al. Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2. Hepatol Int. 2014;8(4):550-9doi: 10.1007/s12072-014-9572-2.
Seki, N., Sugita, T., Aida, Y., Itagaki, M., Ishiguro, H., Sutoh, S., Abe, H., Tsubota, A., Matsushima, M., & Aizawa, Y. (2014). Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2. Hepatology international, 8(4), 550-9. https://doi.org/10.1007/s12072-014-9572-2
Seki, Nobuyoshi, et al. "Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2." Hepatology international vol. 8,4 (2014): 550-9. doi: https://doi.org/10.1007/s12072-014-9572-2
Seki N, Sugita T, Aida Y, Itagaki M, Ishiguro H, Sutoh S, Abe H, Tsubota A, Matsushima M, Aizawa Y. Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2. Hepatol Int. 2014 Oct;8(4):550-9. doi: 10.1007/s12072-014-9572-2. Epub 2014 Sep 26. PMID: 26202760.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2348 entries